6505NCM241134: PYRIDOSTIGMINE BROMIDE TABLETS.
The PYRIDOSTIGMINE BROMIDE TABLETS is a the manufacturer industrial component. Key specifications include administration: ORAL, long_action_method: EXTENDED RELEASE, total_primary_container_quantity: 70, active_medicament_medicinal_strength: 105.0 MILLIGRAMS PYRIDOSTIGMINE BROMIDE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: PYRIDOSTIGMINE BROMIDE EXTENDED-RELEASE TABLETS, 105MG, 70S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-725-2767, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| long_action_method | EXTENDED RELEASE |
| total_primary_container_quantity | 70 |
| active_medicament_medicinal_strength | 105.0 MILLIGRAMS PYRIDOSTIGMINE BROMIDE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | PYRIDOSTIGMINE BROMIDE EXTENDED-RELEASE TABLETS, 105MG, 70S |
| NSN | 6505-01-725-2767 |
| LONG ACTION METHOD | EXTENDED RELEASE |
| ADMINISTRATION | ORAL |
| SPECIAL FEATURES | FOR MILITARY MEDICAL USE ONLY; INDICATED FOR PRE-TREATMENT AGAINST THE LETHAL EFFECTS OF SOMAN NERVE AGENT POISONING IN ADULTS; USE IN CONJUNCTION WITH PROTECTIVE GARMENTS, INCLUDING A MASK; STORE AT 20 C TO 25 C (68 F TO 77 F); EXCURSIONS PERMITTED BETWEEN 15 C TO 30 C (59 F TO 86 F) (SEE USP CONTROLLED ROOM TEMPERATURE), OR STORE REFRIGERATED BETWEEN 2 C AND 8 C (36 F TO 46 F). PROTECT FROM HEAT AND MOISTURE. DISCARD CONTENTS OF BLISTER PACK 3 MONTHS AFTER THE MYLAR BAG IS OPENED; EACH EXTENDED-RELEASE TABLETS CONTAIN 105 MG OF PYRIDOSTIGMINE BROMIDE (EQUIVALENT TO 72.87 MG OF PYRIDOSTIGMINE BASE) FOR ORAL ADMINISTRATION; BAG OF 10 BLISTER PACK, EACH BLISTER PACK CONTAINS 7 TABLETS. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | PYRIDOSTIGMINE BROMIDE EXTENDED-RELEASE TABLETS, 105MG, 70S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 105.0 MILLIGRAMS PYRIDOSTIGMINE BROMIDE ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 70 |